Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Long-Term Investments (2023 - 2025)

Metagenomi (MGX) has disclosed Long-Term Investments for 3 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Investments fell 37.51% to $2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 million, a 37.51% decrease, with the full-year FY2025 number at $2.2 million, down 37.51% from a year prior.
  • Long-Term Investments was $2.2 million for Q4 2025 at Metagenomi, up from $1.3 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $10.6 million in Q3 2024 to a low of $1.3 million in Q1 2025.
  • A 3-year average of $6.4 million and a median of $8.5 million in 2023 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: soared 50.79% in 2024, then tumbled 84.84% in 2025.
  • Metagenomi's Long-Term Investments stood at $8.5 million in 2023, then crashed by 59.55% to $3.4 million in 2024, then crashed by 37.51% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Long-Term Investments are $2.2 million (Q4 2025), $1.3 million (Q1 2025), and $3.4 million (Q4 2024).